ATE245440T1 - Zusammensetzung enthaltend il-18 und topotecan zur behandulung und/oder vorbeugung von krebs - Google Patents

Zusammensetzung enthaltend il-18 und topotecan zur behandulung und/oder vorbeugung von krebs

Info

Publication number: ATE245440T1
Authority: AT; Austria
Prior art keywords: topotecan; cancer; prevention; treatment; composition containing
Prior art date: 1998-05-21

Application number

AT99952068T

Other languages

English (en)

Inventor

Randall K Johnson

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-21

Filing date

1999-05-20

Publication date

2003-08-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22199389&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE245440(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-05-20 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2003-08-15 Application granted granted Critical

2003-08-15 Publication of ATE245440T1 publication Critical patent/ATE245440T1/de

Links

206010028980 Neoplasm Diseases 0.000 title 1
201000011510 cancer Diseases 0.000 title 1
230000002265 prevention Effects 0.000 title 1
UCFGDBYHRUNTLO-QHCPKHFHSA-N topotecan Chemical compound C1=C(O)C(CN(C)C)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 UCFGDBYHRUNTLO-QHCPKHFHSA-N 0.000 title 1
229960000303 topotecan Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)

AT99952068T 1998-05-21 1999-05-20 Zusammensetzung enthaltend il-18 und topotecan zur behandulung und/oder vorbeugung von krebs ATE245440T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8656098P	1998-05-21	1998-05-21
PCT/US1999/011160 WO1999059565A1 (en)	1998-05-21	1999-05-20	Novel compositions

Publications (1)

Publication Number	Publication Date
ATE245440T1 true ATE245440T1 (de)	2003-08-15

Family

ID=22199389

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99952068T ATE245440T1 (de)	1998-05-21	1999-05-20	Zusammensetzung enthaltend il-18 und topotecan zur behandulung und/oder vorbeugung von krebs

Country Status (27)

Country	Link
US (1)	US6582689B1 (de)
EP (1)	EP1079818B1 (de)
JP (1)	JP4283998B2 (de)
KR (1)	KR100624588B1 (de)
CN (1)	CN1227027C (de)
AR (1)	AR019844A1 (de)
AT (1)	ATE245440T1 (de)
AU (1)	AU750918B2 (de)
BR (1)	BR9910622A (de)
CA (1)	CA2328603A1 (de)
CO (1)	CO5050337A1 (de)
CZ (1)	CZ300496B6 (de)
DE (1)	DE69909781T2 (de)
DK (1)	DK1079818T3 (de)
ES (1)	ES2204164T3 (de)
GC (1)	GC0000102A (de)
HU (1)	HUP0600520A2 (de)
IL (2)	IL139733A0 (de)
MY (1)	MY123434A (de)
NO (1)	NO329195B1 (de)
NZ (1)	NZ508115A (de)
PL (1)	PL200840B1 (de)
PT (1)	PT1079818E (de)
TR (1)	TR200003453T2 (de)
TW (1)	TWI227136B (de)
WO (1)	WO1999059565A1 (de)
ZA (1)	ZA200006675B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002101049A2 (en)	2001-03-08	2002-12-19	Ares Trading S.A.	Interleukin-18 mutants, their production and use
US20050079153A1 (en) *	2002-08-14	2005-04-14	Pfizer Inc.	Methods for enhancing immune functions in neonatal mammals by administration of IL-18
AU2003295331A1 (en) *	2002-09-19	2004-04-23	Centocor, Inc.	Method of inducing maturation of dendritic cells and uses therefor
AU2005277404A1 (en) *	2004-08-20	2006-03-02	Smithkline Beecham Corporation	Methods of healing wounds by administering human IL-18
EP2059253A4 (de) *	2006-09-14	2011-09-14	Univ Pennsylvania	Modulation regulatorischer t-zellen mittels human-il-18
PE20090190A1 (es) *	2007-03-23	2009-03-22	Smithkline Beecham Corp	Combinacion de anticuerpos anti-cd20 y polipeptidos de il-18
GB0803352D0 (en)	2008-02-22	2008-04-02	Ntnu Technology Transfer As	Oligopeptidic compounds and uses thereof
US8168165B2 (en) *	2008-12-23	2012-05-01	Abbott Laboratories	Alkylated interleukin-18 compositions
TW201506402A (zh) *	2013-08-15	2015-02-16	Tonyar Biotech Inc	自體防潮的檢驗芯片及其製造方法
IL272635B2 (en) *	2017-09-06	2024-02-01	Univ Yale	Variants of interleukin-18 and methods of use
JP2023550545A (ja)	2020-11-02	2023-12-01	シムハ・アイエル－１８・インコーポレイテッド	インターロイキン－１８バリアントおよび使用の方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2697752B1 (fr) *	1992-11-10	1995-04-14	Rhone Poulenc Rorer Sa	Compositions antitumorales contenant des dérivés du taxane.
JP4004088B2 (ja) *	1995-09-26	2007-11-07	株式会社林原生物化学研究所	免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
TW464656B (en) *	1994-11-15	2001-11-21	Hayashibara Biochem Lab	Interferon-gamma production inducing polypeptide monoclonal antibody, and agent for interferon-gamma susceptive disease
US6207641B1 (en) *	1995-03-10	2001-03-27	Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo	Pharmaceutical composition containing IFN-γ inducing polypeptide or factor for treating and/or preventing IFN-γ susceptive diseases
US5869535A (en) *	1995-03-21	1999-02-09	The Board Of Trustees Of The University Of Illinois	Method and composition for selectively inhibiting melanoma
JP4024366B2 (ja) *	1996-11-29	2007-12-19	株式会社林原生物化学研究所	ポリペプチド

1999
- 1999-05-17 TW TW088107944A patent/TWI227136B/zh not_active IP Right Cessation
- 1999-05-19 GC GCP1999159 patent/GC0000102A/xx active
- 1999-05-19 MY MYPI99001971A patent/MY123434A/en unknown
- 1999-05-20 EP EP99952068A patent/EP1079818B1/de not_active Expired - Lifetime
- 1999-05-20 AR ARP990102416A patent/AR019844A1/es active IP Right Grant
- 1999-05-20 JP JP2000549230A patent/JP4283998B2/ja not_active Expired - Fee Related
- 1999-05-20 AU AU43094/99A patent/AU750918B2/en not_active Ceased
- 1999-05-20 US US09/700,609 patent/US6582689B1/en not_active Expired - Fee Related
- 1999-05-20 CO CO99030928A patent/CO5050337A1/es unknown
- 1999-05-20 ES ES99952068T patent/ES2204164T3/es not_active Expired - Lifetime
- 1999-05-20 CN CNB998089842A patent/CN1227027C/zh not_active Expired - Fee Related
- 1999-05-20 WO PCT/US1999/011160 patent/WO1999059565A1/en not_active Ceased
- 1999-05-20 HU HU0600520A patent/HUP0600520A2/hu unknown
- 1999-05-20 CA CA002328603A patent/CA2328603A1/en not_active Abandoned
- 1999-05-20 CZ CZ20004321A patent/CZ300496B6/cs not_active IP Right Cessation
- 1999-05-20 IL IL13973399A patent/IL139733A0/xx unknown
- 1999-05-20 AT AT99952068T patent/ATE245440T1/de active IP Right Revival
- 1999-05-20 DE DE69909781T patent/DE69909781T2/de not_active Expired - Lifetime
- 1999-05-20 KR KR1020007013014A patent/KR100624588B1/ko not_active Expired - Fee Related
- 1999-05-20 NZ NZ508115A patent/NZ508115A/en not_active IP Right Cessation
- 1999-05-20 BR BR9910622-1A patent/BR9910622A/pt not_active Application Discontinuation
- 1999-05-20 PL PL366170A patent/PL200840B1/pl not_active IP Right Cessation
- 1999-05-20 PT PT99952068T patent/PT1079818E/pt unknown
- 1999-05-20 TR TR2000/03453T patent/TR200003453T2/xx unknown
- 1999-05-20 DK DK99952068T patent/DK1079818T3/da active
2000
- 2000-11-15 ZA ZA200006675A patent/ZA200006675B/en unknown
- 2000-11-16 IL IL139733A patent/IL139733A/en not_active IP Right Cessation
- 2000-11-20 NO NO20005857A patent/NO329195B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP1079818A4 (de)	2001-12-12
TR200003453T2 (tr)	2001-10-22
DE69909781D1 (de)	2003-08-28
JP2003509333A (ja)	2003-03-11
GC0000102A (en)	2005-06-29
IL139733A (en)	2009-06-15
KR100624588B1 (ko)	2006-09-18
MY123434A (en)	2006-05-31
CZ20004321A3 (en)	2001-05-16
JP4283998B2 (ja)	2009-06-24
PT1079818E (pt)	2004-02-27
IL139733A0 (en)	2002-02-10
EP1079818A1 (de)	2001-03-07
DK1079818T3 (da)	2004-04-19
PL200840B1 (pl)	2009-02-27
AR019844A1 (es)	2002-03-20
ZA200006675B (en)	2002-02-27
NO20005857L (no)	2000-11-21
US6582689B1 (en)	2003-06-24
CZ300496B6 (cs)	2009-06-03
EP1079818B1 (de)	2003-07-23
CN1367686A (zh)	2002-09-04
ES2204164T3 (es)	2004-04-16
AU750918B2 (en)	2002-08-01
TWI227136B (en)	2005-02-01
BR9910622A (pt)	2001-01-30
CA2328603A1 (en)	1999-11-25
HK1035136A1 (en)	2001-11-16
AU4309499A (en)	1999-12-06
KR20010052369A (ko)	2001-06-25
PL366170A1 (en)	2005-01-24
CN1227027C (zh)	2005-11-16
NZ508115A (en)	2003-12-19
CO5050337A1 (es)	2001-06-27
DE69909781T2 (de)	2004-05-27
HUP0600520A2 (en)	2006-10-28
NO20005857D0 (no)	2000-11-20
NO329195B1 (no)	2010-09-13
WO1999059565A1 (en)	1999-11-25

Legal Events

Date

Code

Title

Description

2004-01-15

RER

Ceased as to paragraph 5 lit. 3 law introducing patent treaties

2004-03-15

EEWE

Authorization for restitution

2004-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1079818

Country of ref document: EP

Publication	Publication Date	Title
DE69942680D1 (de)	2010-09-23	Verfahren und Zusammensetzungen zur Prävention und Behandlung von Anämie
EP1085892A4 (de)	2002-07-17	Impfstrategie zur vorbeugung und behandlung von krebs
ATE363904T1 (de)	2007-06-15	Benzimidazol-2-carbamat zur behandlung viraler infektionen und von krebs
ATE265857T1 (de)	2004-05-15	Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
AU6147401A (en)	2001-11-26	Compositions and methods for the treatment of cancer
PT1231887E (pt)	2013-02-21	Método e composição para o tratamento de cicatrizes
AU2002364364A8 (en)	2003-07-24	Method of treating apoptosis and compositions thereof
DE69404384D1 (de)	1997-09-04	Mittel zur Oberflächenbehandlung von Kupfer und Kupferlegierungen
HUP0104688A3 (en)	2004-07-28	Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
KR100510795B1 (en)	2005-08-30	Compositions and Methods for the Treatment of Tumor
DE60030554T8 (de)	2008-01-10	Verwendungen von et743 zur behandlung von krebs
DE60229959D1 (de)	2009-01-02	Kombinationstherapie zur behandlung von krebs
NZ514044A (en)	2001-09-28	Herbal compositions and uses for the treatment of allergic reactions
ATE245440T1 (de)	2003-08-15	Zusammensetzung enthaltend il-18 und topotecan zur behandulung und/oder vorbeugung von krebs
DE69714862D1 (de)	2002-09-26	Lösungen und verfahren zur oberblächenbehandlung von metallen
IL158206A0 (en)	2004-05-12	Compositions and methods for the prevention and treatment of human prostate cancer
DE60002226D1 (de)	2003-05-22	Zusammensetzung zur vorbeugung und/oder behandlung von kreislaufstörungen, enthaltend l-carnitin derivate und ginkgo biloba extrakte
DE69825319D1 (de)	2004-09-02	Präparat zur vorbeugung und behandlung von entzündungen
IL143212A0 (en)	2002-04-21	Compositions and methods for the treatment of tumor
IL141426A0 (en)	2002-03-10	Compositions and methods for the treatment of tumor
NO994631D0 (no)	1999-09-23	Fremgangsmaater og sammensetninger for behandling av eggstokkreft
PL368035A1 (en)	2005-03-21	Compositions and methods for the treatment of cancer
NO20001758D0 (no)	2000-04-05	Fremgangsmåter og blandinger for behandling av leddgikt
FR2786096B1 (fr)	2002-10-18	Composition pour la prevention et le traitement topique de la cellulite
EE200300057A (et)	2004-12-15	Koostis vähi profülaktikaks ja raviks